Skip to main content

Table 3 Univariate and multivariate Cox regression analysis of predictors of device-related infection in the overall and matched cohorts

From: Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study

 

Overall cohorts

 

Matched cohorts

Univariate analysis

Multivariate analysis

 

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

 

HR (95% CI)

P value

HR (95% CI)

P value

Age, (years)

1.02 (0.98–1.06)

0.447

   

1.05 (0.97–1.12)

0.220

  

Male

1.01 (0.45–2.31)

0.974

   

0.35 (0.09–1.32)

0.120

0.48 (0.11–2.07)

0.327

Body mass index, (kg/m2)

0.96 (0.87–1.05)

0.335

   

0.85 (0.70–1.02)

0.075

0.88 (0.72–1.07)

0.206

Hypertension

0.64 (0.30–1.38)

0.255

   

1.10 (0.36–3.33)

0.866

  

Diabetes mellitus

0.75 (0.35–1.58)

0.447

   

0.21 (0.04–1.01)

0.051

0.43 (0.07–2.64)

0.362

Hyperlipidemia

0.67 (0.30–1.49)

0.327

   

1.03 (0.22–4.80)

0.970

  

Coronary artery disease

1.41 (0.55–3.58)

0.476

   

1.05 (0.31–3.50)

0.939

  

Heart failure history

0.96 (0.39–2.40)

0.934

   

1.22 (0.26–5.78)

0.802

  

Atrial fibrillation

0.54 (0.26–1.15)

0.112

0.60 (0.27–1.31)

0.198

 

0.76 (0.25–2.35)

0.637

  

Cerebrovascular accident

1.36 (0.54–3.42)

0.514

   

0.96 (0.21–4.45)

0.954

  

Chronic kidney disease

1.88 (0.77–4.58)

0.165

1.56 (0.62–3.94)

0.343

 

1.65 (0.52–5.23)

0.397

  

End-stage renal disease

1.32 (0.17–9.97)

0.789

   

N/A

N/A

  

Anemia

1.49 (0.62–3.58)

0.378

   

0.82 (0.25–2.70)

0.750

  

Intravenous temporary pacemaker

1.42 (0.58–3.50)

0.441

   

0.69 (0.18–2.59)

0.580

  

Complex procedure

1.07 (0.47–2.45)

0.868

   

2.24 (0.62–8.12)

0.219

  

Pocket hematoma

1.30 (0.45–3.78)

0.632

   

0.75 (0.16–3.60)

0.723

  
  1. The definitions of parameters are the same as Table 1. CI = confidence interval; HR = harzard ratio